Post-Myelogram Seizure Risk
A 62-year-old male is scheduled for a lumbar myelogram with iohexol (Omnipaque) 300 mg I/mL. He has a history of hypertension, type 2 diabetes, and a seizure disorder controlled with levetiracetam. His creatinine is 1.8 mg/dL (eGFR 38 mL/min/1.73 m²). He takes metformin. The radiologist plans to use 10 mL of contrast. During the procedure, the patient reports a metallic taste and mild nausea. After the procedure, he is alert and oriented but has a headache.
1. What are the key risk factors for contrast-induced seizure in this patient, and how should the technologist modify the procedure?
Read the worked answer
Key risk factors: history of seizure disorder, renal impairment (eGFR 38), and use of ionic contrast? Actually iohexol is nonionic, but the osmolality and volume matter. The metallic taste and nausea may indicate contrast reaching the intracranial subarachnoid space, increasing seizure risk. The technologist should: ensure minimal volume of contrast, use nonionic low-osmolar contrast, keep the head elevated 30-45 degrees for 2-4 hours post-procedure, monitor for seizures, and have suction and oxygen available. Also, metformin should be withheld for 48 hours after contrast due to renal impairment.
2. What post-procedure instructions should the technologist reinforce regarding metformin and seizure precautions?
Read the worked answer
The technologist should instruct the patient to withhold metformin for 48 hours after the procedure and to resume only after renal function is rechecked and stable. Regarding seizure precautions: take anti-seizure medication as prescribed, avoid driving or operating machinery for 24 hours, and seek immediate medical attention if seizure activity occurs. Also, maintain hydration and report any new symptoms like confusion or visual changes.